Stay informed with the latest litigation news. Explore now

IP Verse

Method Of Assessing Risk Of Pml - EP3575792B1

EP3575792

BIOGEN MA
Application Number
EP19169482A
Filing Date
May 31, 2012
Status
Granted And Under Opposition
Oct 28, 2022
Grant Date
Nov 30, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2645106B2
EP3036320B2
EP2956477B2

Bibliography

The patent EP3575792B1 was granted to Biogen MA on Nov 30, 2022 following the initial filing on May 31, 2012 under the application number EP19169482A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZAug 30, 2023ADMISSIBLE
POLPHARMA BIOLOGICSDec 1, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents